PURE BIOSCIENCE, INC. Share-based Payment Arrangement, Expense in USD from Q4 2012 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pure Bioscience, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2012 to 2025.
  • Pure Bioscience, Inc. Share-based Payment Arrangement, Expense for the quarter ending October 31, 2024 was $57K, a 28.8% decline year-over-year.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $144K, a 32.7% decline from 2024.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $214K, a 18.3% decline from 2023.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $262K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

PURE BIOSCIENCE, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $57K -$23K -28.8% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q3 2023 $80K +$17K +27% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q3 2022 $63K -$106K -62.7% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-14
Q3 2021 $169K -$39K -18.8% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q3 2020 $208K -$60K -22.4% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q4 2019 $477K $68K -$176K -72.1% Nov 1, 2019 Jan 31, 2020 10-Q 2020-03-12
Q3 2019 $653K $268K -$734K -73.3% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-15
Q2 2019 $1.39M $58K May 1, 2019 Jul 31, 2019 10-K 2020-10-08
Q1 2019 $83K -$143K -63.3% Feb 1, 2019 Apr 30, 2019 10-Q 2019-06-13
Q4 2018 $244K -$212K -46.5% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-12
Q3 2018 $1M Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-13
Q1 2018 $226K Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-13
Q4 2017 $456K Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-06
Q2 2016 $1.9M $281K -$350K -55.5% May 1, 2016 Jul 31, 2016 10-K 2016-10-27
Q1 2016 $2.25M $186K -$580K -75.7% Feb 1, 2016 Apr 30, 2016 10-Q 2016-06-09
Q4 2015 $2.83M $763K +$281K +58.3% Nov 1, 2015 Jan 31, 2016 10-Q 2016-03-09
Q3 2015 $2.55M $672K +$169K +33.6% Aug 1, 2015 Oct 31, 2015 10-Q 2015-12-10
Q2 2015 $2.38M $631K -$136K -17.7% May 1, 2015 Jul 31, 2015 10-K 2016-10-27
Q1 2015 $2.52M $766K -$4K -0.52% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-09
Q4 2014 $2.52M $482K -$850K -63.8% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 $3.37M $503K +$414K +465% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q2 2014 $2.96M $767K May 1, 2014 Jul 31, 2014 10-K 2015-10-28
Q1 2014 $770K +$617K +403% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-11
Q4 2013 $1.33M +$1.09M +450% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-04
Q3 2013 $89K Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-11
Q1 2013 $153K Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 $242K Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-13

PURE BIOSCIENCE, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $144K -$70K -32.7% Aug 1, 2024 Jul 31, 2025 10-K 2025-10-29
2024 $214K -$48K -18.3% Aug 1, 2023 Jul 31, 2024 10-K 2025-10-29
2023 $262K Aug 1, 2022 Jul 31, 2023 10-K 2024-10-29
2021 $758K +$203K +36.6% Aug 1, 2020 Jul 31, 2021 10-K 2021-10-28
2020 $555K -$832K -60% Aug 1, 2019 Jul 31, 2020 10-K 2020-10-08
2019 $1.39M -$138K -9.05% Aug 1, 2018 Jul 31, 2019 10-K 2020-10-08
2018 $1.53M Aug 1, 2017 Jul 31, 2018 10-K 2019-10-30
2016 $1.9M -$480K -20.2% Aug 1, 2015 Jul 31, 2016 10-K 2016-10-27
2015 $2.38M -$576K -19.5% Aug 1, 2014 Jul 31, 2015 10-K 2016-10-27
2014 $2.96M +$2.24M +311% Aug 1, 2013 Jul 31, 2014 10-K 2015-10-28
2013 $720K Aug 1, 2012 Jul 31, 2013 10-K 2014-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.